JW Group Joins Hands with U.S. Venture Capital to Promote Open Innovation
The Business Korea website reported that the JW Group has signed a business agreement with ARCH Venture Partners, a U.S. venture capital to promote open innovation with global biotech companies. This is the first time that a Korean pharmaceutical company has joined hands with a biotech and healthcare venture capital firm in the United States to promote
Comments Off on JW Group Joins Hands with U.S. Venture Capital to Promote Open Innovation • Read this story »